981 related articles for article (PubMed ID: 17128305)
1. Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system.
Lima VC; Mattos LA; Caramori PR; Perin MA; Mangione JA; Machado BM; Coelho WM; Bueno RR
Arq Bras Cardiol; 2006 Oct; 87(4):e162-7. PubMed ID: 17128305
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of sirolimus-eluting stents in percutaneous coronary interventions in Brazil.
Polanczyk CA; Wainstein MV; Ribeiro JP
Arq Bras Cardiol; 2007 Apr; 88(4):464-74. PubMed ID: 17546279
[TBL] [Abstract][Full Text] [Related]
3. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.
Silber S; Albertsson P; Avilés FF; Camici PG; Colombo A; Hamm C; Jørgensen E; Marco J; Nordrehaug JE; Ruzyllo W; Urban P; Stone GW; Wijns W;
Eur Heart J; 2005 Apr; 26(8):804-47. PubMed ID: 15769784
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
[TBL] [Abstract][Full Text] [Related]
7. Proximal left anterior descending coronary artery revascularization with drug-eluting stents.
Guardado JH; Moreno R; Costa J; Perez-Viscayno MJ; Segura L; Alfonso F; Hernández R; Escaned J; Bañuelos C; Macaya C
Arq Bras Cardiol; 2007 Feb; 88(2):159-66. PubMed ID: 17384832
[TBL] [Abstract][Full Text] [Related]
8. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
9. Prevention of restenosis after coronary angioplasty.
Karthikeyan G; Bhargava B
Curr Opin Cardiol; 2004 Sep; 19(5):500-9. PubMed ID: 15316460
[TBL] [Abstract][Full Text] [Related]
10. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center.
Ferreira AC; Peter AA; Salerno TA; Bolooki H; de Marchena E
Ann Thorac Surg; 2003 Feb; 75(2):485-9. PubMed ID: 12607658
[TBL] [Abstract][Full Text] [Related]
13. Effect of hospital ownership status and payment structure on the adoption and use of drug-eluting stents for percutaneous coronary interventions.
Grilli R; Guastaroba P; Taroni F
CMAJ; 2007 Jan; 176(2):185-90. PubMed ID: 17179220
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of sirolimus-eluting stents.
Shrive FM; Manns BJ; Galbraith PD; Knudtson ML; Ghali WA;
CMAJ; 2005 Feb; 172(3):345-51. PubMed ID: 15684117
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of drug-eluting stents: the next revolution.
Moses JW; Kipshidze N; Leon MB
Am J Cardiovasc Drugs; 2002; 2(3):163-72. PubMed ID: 14727979
[TBL] [Abstract][Full Text] [Related]
16. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
Ardissino D; Cavallini C; Bramucci E; Indolfi C; Marzocchi A; Manari A; Angeloni G; Carosio G; Bonizzoni E; Colusso S; Repetto M; Merlini PA;
JAMA; 2004 Dec; 292(22):2727-34. PubMed ID: 15585732
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of drug-eluting stents: current best available evidence.
Raja SG; Dreyfus GD
J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting versus bare-metal coronary stents: where are we now?
Amoroso NS; Bangalore S
J Comp Eff Res; 2012 Nov; 1(6):501-8. PubMed ID: 24236469
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
